Skip to main content
Search hero banner

Search results

Showing 481 - 500 of 1142 results

ANSTO Hosted IAEA Pacific Islands Workshop in February 2024

In early February, ANSTO was honoured to host the International Atomic Energy Agency (IAEA) National Liaison Officers Meeting and Sub Regional Approach to the Pacific Islands (SAPI) Programme, which focused on the development and delivery of the IAEA Technical Cooperation Programme in the Pacific.

High Performance Macromolecular Crystallography Beamline (MX3)

High Performance Macromolecular Crystallography Beamline (MX3)

The High Performance Macromolecular Crystallography beamline will enable the study of very small (sub-5 micrometre) or weakly diffracting crystals, providing a state-of-the-art high-throughput facility for researchers. MX3 will be able to study the structures of large proteins and protein complexes for virology, drug design and industrial applications via goniometer mounted crystals, in-tray screening, or via serial crystallography methods.

business-services-health-ansto

Nuclear Medicine

ANSTO manufacture and supply a range of radiopharmaceuticals, radiochemicals, kits and accessories for use in research, industry and the health sector.

ANSTO welcomes $13.9M critical minerals funding

Rare earth elements will be a key area of focus for the Australian Nuclear Science and Technology Organisation’s Minerals unit as it welcomes a $13.9 million funding allocation under the Australian Critical Minerals Research and Development Hub

Gentech Generator

Gentech Generator

Developed by ANSTO’s predecessor the Australian Atomic Energy Commission (known as the AAEC) in the late 1960s, the Technetium-99m Generator revolutionised nuclear medicine imaging in Australia by enabling imaging procedures to be performed not only in major capital cities but throughout regional and rural Australia.

Pagination